BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mawson AR, Majumdar S. Malaria, Epstein-Barr virus infection and the pathogenesis of Burkitt's lymphoma. Int J Cancer 2017;141:1849-55. [PMID: 28707393 DOI: 10.1002/ijc.30885] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Hartung A, Makarewicz O, Egerer R, Karrasch M, Klink A, Sauerbrei A, Kentouche K, Pletz MW. EBV miRNA expression profiles in different infection stages: A prospective cohort study. PLoS One 2019;14:e0212027. [PMID: 30759142 DOI: 10.1371/journal.pone.0212027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Chen Y, Mei X, Gan D, Wu Z, Cao Y, Lin M, Zhang N, Yang T, Chen Y, Hu J. Integration of bioinformatics and experiments to identify TP53 as a potential target in Emodin inhibiting diffuse large B cell lymphoma. Biomed Pharmacother 2018;107:226-33. [PMID: 30096626 DOI: 10.1016/j.biopha.2018.07.168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cui X, Cao Z, Ishikawa Y, Cui S, Imadome KI, Snapper CM. Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge. Vaccines (Basel) 2021;9:285. [PMID: 33808755 DOI: 10.3390/vaccines9030285] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
4 Soliman SHA, Orlacchio A, Verginelli F. Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis. Microorganisms 2021;9:1179. [PMID: 34070716 DOI: 10.3390/microorganisms9061179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shannon-Lowe C, Rickinson A. The Global Landscape of EBV-Associated Tumors. Front Oncol 2019;9:713. [PMID: 31448229 DOI: 10.3389/fonc.2019.00713] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 33.7] [Reference Citation Analysis]
6 Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Estimating the global burden of Epstein-Barr virus-related cancers. J Cancer Res Clin Oncol 2021. [PMID: 34705104 DOI: 10.1007/s00432-021-03824-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ellis T, Eze E, Raimi-Abraham BT. Malaria and Cancer: a critical review on the established associations and new perspectives. Infect Agent Cancer 2021;16:33. [PMID: 33985540 DOI: 10.1186/s13027-021-00370-7] [Reference Citation Analysis]
8 Melenotte C, Mezouar S, Mège JL, Gorvel JP, Kroemer G, Raoult D. Bacterial infection and non-Hodgkin's lymphoma. Crit Rev Microbiol 2020;46:270-87. [PMID: 32412856 DOI: 10.1080/1040841X.2020.1760786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Sidorov S, Fux L, Steiner K, Bounlom S, Traxel S, Azzi T, Berisha A, Berger C, Bernasconi M, Niggli FK, Perner Y, Pather S, Kempf W, Nadal D, Bürgler S. CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein-Barr virus genes. Cancer Immunol Immunother 2021. [PMID: 34668039 DOI: 10.1007/s00262-021-03057-5] [Reference Citation Analysis]
10 Cui X, Snapper CM. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Front Immunol 2021;12:734471. [PMID: 34691042 DOI: 10.3389/fimmu.2021.734471] [Reference Citation Analysis]